Vascular Endothelial Growth Factor Inhibitors
- Name
- Vascular Endothelial Growth Factor Inhibitors
- Accession Number
- DBCAT004320
- Description
Not Available
- Drugs
Drug Drug Description Aflibercept A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer Ranibizumab A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. Bevacizumab A monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer. - Drugs & Drug Targets